J&J aims to 'save legs, change lives' with new peripheral artery disease awareness effort

Peripheral artery disease, or PAD, is a leading cause of amputations in the U.S. | Peripheral artery disease, or PAD, is a leading cause of amputations in the U.S. But the disease can be silent, so millions of Americans—especially Black Americans—don’t know they have it until it’s too late. Johnson & Johnson’s Janssen unit is hoping to change that with a new awareness initiative.

ESVM Guideline on peripheral arterial disease

About Us Save Legs. Change Lives™

Deborah Epps, PharmD on LinkedIn: J&J aims to 'save legs, change

Amy Carmen-Hall on LinkedIn: National Peripheral Artery Disease

Revolutionary Solutions: Improving Outcomes for Peripheral Artery

Kenneth Todd Moore on LinkedIn: J&J aims to 'save legs, change

Intravascular ultrasound use in peripheral arterial and deep

Amy Carmen-Hall posted on LinkedIn

Jon Bloom, M.D. on LinkedIn: Video Severed: Diabetes Denial and

Editor's Choice -- European Society for Vascular Surgery (ESVS

Peripheral Matters Peripheral Artery Disease: Moving From

Official Website Save Legs. Change Lives™

Save Legs. Change Lives.™ Paves the Way for Change